Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis

OBJECTIVES: Soluble urokinase plasminogen activated receptor (suPAR) is a biomarker that may predict the occurrence of focal segmental glomerulosclerosis (FSGS); however, there is still controversy about whether suPAR can predict FSGS. In this study, we performed a systematic evaluation and meta-ana...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Shuai, Tiankui, Pei Jing, Yan, Huang, Qiangru, Xiong, Huaiyu, Liu, Jingjing, Zhu, Lei, Yang, Kehu, Jian, Liu
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Renal Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797292/
https://ncbi.nlm.nih.gov/pubmed/31594897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031812
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars